Indole-pyrimidine hybrids with anticancer therapeutic potential

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Oncology

Background:

• Indole derivatives are versatile anticancer agents targeting cancer hallmarks like proliferation and apoptosis.
• Pyrimidine derivatives act as molecular mimics or enzyme inhibitors, exploiting cancer-specific vulnerabilities.
• Hybridizing indole and pyrimidine scaffolds offers a promising strategy for novel anticancer therapeutics.

Purpose of the Study:

• To review the current landscape of indole-pyrimidine hybrids with anticancer potential.
• To summarize structure-activity relationships and mechanisms of action for these hybrids.
• To guide the rational design of new anticancer drug candidates.

Main Methods:

• Literature search for indole-pyrimidine hybrids with anticancer activity published from 2021 to date.
• Analysis of structure-activity relationships (SAR) of identified compounds.
• Discussion of mechanisms of action for promising drug candidates.

Main Results:

• Identified a growing body of research on indole-pyrimidine hybrids demonstrating significant anticancer potential.
• Detailed SAR studies reveal key structural features contributing to efficacy.
• Mechanisms of action involve targeting multiple cancer pathways.

Conclusions:

• Indole-pyrimidine hybrids represent a potent class of anticancer agents with diverse mechanisms.
• Further research into SAR and mechanisms will facilitate the development of novel therapeutics.
• This hybrid scaffold holds significant promise for future cancer drug discovery.